ACTH analog

4 marketed 1 in Phase 3

This page covers all ACTH analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Melanocortin-2 receptor (MC2R).

Targets

Melanocortin-2 receptor (MC2R)

Marketed (4)

Phase 3 pipeline (1)